Maze Therapeutics, Inc.
General ticker "MAZE" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $709.9M (TTM average)
Maze Therapeutics, Inc. follows the US Stock Market performance with the rate: 50.0%.
Estimated limits based on current volatility of 3.3%: low 39.13$, high 41.79$
Factors to consider:
- Total employees count: 13500 as of 2024
Short-term MAZE quotes
Long-term MAZE plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 |
|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM |
| Operating Expenses | $111.03MM | $98.55MM |
| Operating Income | $-111.03MM | $-98.55MM |
| Non-Operating Income | $-3.91MM | $-1.86MM |
| R&D Expense | $88.19MM | $73.94MM |
| Income(Loss) | $-114.94MM | $-100.42MM |
| Profit(Loss)* | $-114.94MM | $-100.42MM |
| Stockholders Equity | $101.44MM | $10.05MM |
| Assets | $149.96MM | $71.50MM |
| Operating Cash Flow | $-99.20MM | $-86.83MM |
| Capital expenditure | $1.97MM | $0.44MM |
| Investing Cash Flow | $-3.17MM | $-0.44MM |
| Financing Cash Flow | $1.73MM | $16.39MM |
| Earnings Per Share** | $-2.63 | $-2.29 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.